Mast Cell Activation Syndromes Presenting as Anaphylaxis

This publication has 41 references indexed in Scilit:

• Drug allergy in mast cell disease
  Current Opinion in Allergy and Clinical Immunology, 2012
• Prevention of anaphylaxis related to mast cell activation syndrome with omalizumab
  Annals of Allergy, Asthma & Immunology, 2012
• Tryptase and histamine metabolites as diagnostic indicators of indolent systemic mastocytosis without skin lesions
  Allergy, 2012
• Eosinophils as a Novel Cell Source of Prostaglandin D2: Autocrine Role in Allergic Inflammation
  The Journal of Immunology, 2011
• Definitions, Criteria and Global Classification of Mast Cell Disorders with Special Reference to Mast Cell Activation Syndromes: A Consensus Proposal
  International Archives of Allergy and Immunology, 2011
• Improved Detection of the KIT D816V Mutation in Patients with Systemic Mastocytosis Using a Quantitative and Highly Sensitive Real-Time qPCR Assay
  The Journal of Molecular Diagnostics, 2011
• Anaphylaxis in patients with mastocytosis: a study on history, clinical features and risk factors in 120 patients
  Allergy, 2008
• Demonstration of an aberrant mast-cell population with clonal markers in a subset of patients with “idiopathic” anaphylaxis
  Blood, 2007
• Molecular Diagnosis of Mast Cell Disorders
  The Journal of Molecular Diagnostics, 2006
• Idiopathic Anaphylaxis: a Series of 335 Cases
  Annals of Allergy, Asthma & Immunology, 1996